Search
for
Sort by
Research 271–300 of 1000+
- Treating of resistant cases of alopecia universalis
- Cutaneous Drug Reaction Case Reports
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Androgenetic alopecia; drug safety and therapeutic strategies
- NANOEMULGEL AS A RECENT DRUG DELIVERY SYSTEM
- Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Hereditary vitamin D resistant rickets (HVDRR) case series: phenotype, genotype, conventional treatment, and adjunctive cinacalcet therapy
- Impact of Chemotherapeutic Drug on People living with Cancer
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- The PDGF/PDGFR pathway as a drug target
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Efficacy of systemic minoxidil and tofacitinib combination in treatment‐resistant alopecia universalis
- Novel drugs of United States Food and Drug Administration approved in 2024
- In Vivo Evaluation of<i>Eclipta alba</i>Extract as Anticancer and Multidrug Resistance Reversal Agent
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Novel therapies for alopecia areata: The era of rational drug development
- Microgel emulsion loaded with recombinant oil body as a new drug delivery carrier to promote wound repair
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- Lipid-based liquid crystals as drug delivery vehicles for antimicrobial peptides
- LB1154 Rising antimicrobial resistance in chronic wounds
- Androgen sensitivity gateway to COVID‐19 disease severity
- The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic
- Examining polyquaternium polymers deposition on human excised hair fibers